ATE527991T1 - Pharmazeutische zusammensetzungen von pramipexol - Google Patents
Pharmazeutische zusammensetzungen von pramipexolInfo
- Publication number
- ATE527991T1 ATE527991T1 AT10175596T AT10175596T ATE527991T1 AT E527991 T1 ATE527991 T1 AT E527991T1 AT 10175596 T AT10175596 T AT 10175596T AT 10175596 T AT10175596 T AT 10175596T AT E527991 T1 ATE527991 T1 AT E527991T1
- Authority
- AT
- Austria
- Prior art keywords
- pramipexole
- pharmaceutical compositions
- pharmaceutically acceptable
- solvate
- hydrate
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- FASDKYOPVNHBLU-ZETCQYMHSA-N pramipexole Chemical group C1[C@@H](NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-ZETCQYMHSA-N 0.000 title abstract 2
- 229960003089 pramipexole Drugs 0.000 title abstract 2
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940079832 sodium starch glycolate Drugs 0.000 abstract 1
- 229920003109 sodium starch glycolate Polymers 0.000 abstract 1
- 239000008109 sodium starch glycolate Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2009/06997A TR200906997A1 (tr) | 2009-09-11 | 2009-09-11 | Pramipeksol farmasötik bileşimleri. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE527991T1 true ATE527991T1 (de) | 2011-10-15 |
Family
ID=41665020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10175596T ATE527991T1 (de) | 2009-09-11 | 2010-09-07 | Pharmazeutische zusammensetzungen von pramipexol |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2295040B1 (de) |
| AT (1) | ATE527991T1 (de) |
| ES (1) | ES2375265T3 (de) |
| TR (1) | TR200906997A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103181905B (zh) * | 2011-12-27 | 2015-10-28 | 重庆安格龙翔医药科技有限公司 | 一种制备盐酸普拉克索片剂的工艺 |
| CN103040780B (zh) * | 2013-01-04 | 2015-02-25 | 杭州朱养心药业有限公司 | 快速崩解的普拉克索片剂药物组合物及其制备方法 |
| CN103961325B (zh) * | 2013-02-03 | 2018-08-21 | 南京圣和药业股份有限公司 | 普拉克索片剂的制备方法和由此获得的片剂及其应用 |
| DE102016203348A1 (de) | 2016-03-01 | 2017-09-07 | Hp Pelzer Holding Gmbh | Mehrlagiger Akustik- und/oder Versteifungsvliesstoff |
| DE102019104847A1 (de) * | 2019-02-26 | 2020-08-27 | Adler Pelzer Holding Gmbh | Materialstruktur eines Nadelvlieses |
| DE102019110494A1 (de) | 2019-04-23 | 2020-10-29 | Adler Pelzer Holding Gmbh | Absorptiver vernadelter Schichtverbund |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3572485D1 (en) | 1984-12-22 | 1989-09-28 | Thomae Gmbh Dr K | Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs |
| DE19701619B4 (de) | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
| DE10137453A1 (de) | 2001-08-02 | 2003-02-20 | Boehringer Ingelheim Pharma | Pramlpexol als Antikonvulsivum |
| DE10137633A1 (de) | 2001-08-03 | 2003-02-20 | Boehringer Ingelheim Pharma | Pramipexol zur Behandlung von ADHD |
| US20090041844A1 (en) * | 2006-02-10 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Modified Release Formulation |
| WO2008023027A2 (en) * | 2006-08-24 | 2008-02-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for preparing pramipexole dihydrochloride tablets with high storage stability |
| US20080254117A1 (en) * | 2007-04-10 | 2008-10-16 | Noel Cotton | Process for preparing pramipexole dihydrochloride tablets |
| EP2150239A1 (de) * | 2007-04-24 | 2010-02-10 | Boehringer Ingelheim International GmbH | Kombination mit einer pramipexol oder ein pharmazeutisch annehmbares salz davon enthaltenden tablettenformulierung mit verlängerter freisetzung |
| WO2008145252A1 (en) | 2007-05-25 | 2008-12-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical formulation comprising pramipexole |
-
2009
- 2009-09-11 TR TR2009/06997A patent/TR200906997A1/xx unknown
-
2010
- 2010-09-07 ES ES10175596T patent/ES2375265T3/es active Active
- 2010-09-07 EP EP10175596A patent/EP2295040B1/de active Active
- 2010-09-07 AT AT10175596T patent/ATE527991T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2295040A1 (de) | 2011-03-16 |
| TR200906997A1 (tr) | 2011-03-21 |
| ES2375265T3 (es) | 2012-02-28 |
| EP2295040B1 (de) | 2011-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125381T1 (el) | Συνθεση για εισπνοη που περιεχει ακλιδινιο για τη θεραπευτικη αντιμετωπιση της χρονιας αποφρακτικης πνευμονοπαθειας | |
| MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| BR112012021681A2 (pt) | rifaximina em pó, processo para preparação da mesma e composições de liberação controladas contendo a referida rifaximina útil para obtenção de um efeito de longa duração. | |
| UA106636C2 (uk) | Морфолінотіазоли як позитивні алостеричні модулятори альфа 7 | |
| TR200906997A1 (tr) | Pramipeksol farmasötik bileşimleri. | |
| EA201491060A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| EA201291348A1 (ru) | Активаторы растворимой гуанилатциклазы | |
| MX2011013884A (es) | Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas. | |
| ATE517882T1 (de) | Chinolinderivate | |
| TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
| PT2323972E (pt) | Compostos de tetraciclina substituídos com c7-flúor | |
| UY30426A1 (es) | Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones. | |
| ATE536172T1 (de) | Ezetimibzusammensetzungen | |
| AR069031A1 (es) | Composicion | |
| UA116334C2 (uk) | Тверді форми дозування бендамустину | |
| EA201592255A1 (ru) | Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания | |
| MX394588B (es) | Composición farmacéutica. | |
| EA200971086A1 (ru) | Фармацевтические композиции и способ лечения шизофрении | |
| EA200971087A1 (ru) | Фармацевтические композиции и способ лечения острой мании | |
| BR112022000914A2 (pt) | Composição farmacêutica | |
| CY1119710T1 (el) | Συντηγμενες θειαζολο- και οξαζολο-πυριμιδινονες | |
| NZ704171A (en) | Difluorolactam compositions for ep4-mediated osteo related diseases and conditions | |
| DE602007013040D1 (de) | 4-Ä(3-FLUORPHENOXY)PHENYLMETHYLÜPIPERIDINMETHANiSULFONAT: VERWENDUNGEN, SYNTHESEVERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN | |
| MX2009007040A (es) | Derivados de mononitrato de isosorbida para el tratamiento de hipertension ocular. | |
| MY146988A (en) | Fexofenadine suspension formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |